期刊名称：JOURNAL OF MENS HEALTH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Journal of Men's Health is a comprehensive, accessible resource of knowledge directly applicable to the daily care of patients, offering key information and insight about men's health and gender medicine to other healthcare professionals, patient groups and policy makers.
Topics covered include the fields of family medicine and primary care, urology and andrology, internal medicine and oncology, pediatric and adolescent health, sexual medicine, aging and geriatric medicine, nutrition and well being, preventive and sports medicine, mental health including psychosomatic and psychosocial medicine, public health, social medicine, gender medicine, and basic science.
Peer reviewed research and reviews, best practice guidelines, literature overviews, educational materials including self-test CME, commentaries and debate, industry and product news will be published.
Instructions to Authors
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
Abstracts should be structured into the following four paragraphs: Background, Methods, Results, Conclusions. The information in the abstract must correlate with that in the main text. Abbreviations should be kept to a minimum and should be written out in full the first time they are used followed by the abbreviation in parentheses. No references should be cited in the abstract. Abstracts should not exceed 250 words in length.
Keywords should preferably be taken from the MESH index of Index Medicus.
Introduction
The introduction should explain the state of knowledge before the investigation and contain a clear statement of the aim and novelty of the study. It should neither include results nor conclusions.
Subjects, Materials and Methods
Sufficient information should be given to permit repetition of experiments.
Patients and the criteria for their selection must be described. The reasons for any dropping out of the study must be fully explained.
Animals age, sex and source and, where appropriate, genetic background should be given.
Chemical substances must be identified and unless they are standard laboratory chemicals the name, town and country of the supplier must be provided.
Drugs must be identified by their generic or official name. Proprietary names may follow in parentheses (include both English and American names if different). Great care should be taken in describing the use of drugs and details of the regimen should be thoroughly checked.
Units. The International System of Units (SI) should be applied. For abbreviations, capitals without full stops are preferred. If uncommon abbreviations are used they should be defined at first mention.
Genes. Gene names should be those approved by the Human Gene Nomenclature Committee (www.gene.ucl.ac.uk/nomenclature). Italic characters should be used for gene symbols to distinguish them from protein symbols. New gene sequences should be deposited in a public database (GenBank, EMBL or DDBJ), and the accession number provided.
Results
Only important observations should be reported and reference made to details documented in tables and figures. Repetition of data between tables, figures and text must be avoided.
Figures. Instructions on submitting figures online are provided under http://authors.elsevier.com/artwork
All authors wishing to use illustrations already published must first obtain the permission of the author and publisher and/or copyright holder and give the precise reference to the original work. If colour illustrations are essential, please inform the Editorial Office immediately of your requirements; colour figures will be published online at no cost but a charge will be levied to the author to cover print production costs.
Figure Legends. Figure legends should be short but contain sufficient detail to explain the figures and enable them to stand as a separate entity from the text. Details of methods should not be included. These should only be given in the subjects, materials and methods section.
Tables. Authors are encouraged to use tables to show precise numerical details, data, and information (e.g. the general characteristics of the subjects), when these cannot be clearly presented as narrative. A table should have at least three interrelated columns and three rows; a table with less can probably be narrated in the text. Tables should be numbered consecutively using Arabic numerals in the order in which they are cited in the text. Each table should be typed in double spacing and given a brief explanatory caption.
Discussion
The discussion should compare the state of previous knowledge mentioned in the introduction with the new information provided by the results, but without repeating them. It should fairly assess the results and discuss the relevant literature both supporting and contending the findings. The clinical application of the results is important and should be clearly explained.
The discussion and results may be combined in short reports.
Acknowledgements
Only those people who qualify as contributors not meeting the Uniform Requirements for Submission of Manuscripts to Biomedical journal's criteria of authorship ( http://www.icmje.org) should be listed. The source of grant support, equipment and drugs must also be included.
Reference List
Reference Format. These should represent the most recent and pertinent literature available. It is essential that references are thoroughly checked to eliminate inaccuracies.
•A maximum of 50 references should be included. •References should be provided in the Vancouver system.1. •Indicate reference(s) in the text with a number in square brackets [1] to [80]. •At the end of the manuscript provide a corresponding numbered reference list. This should not be alphabetised, but should appear in the same sequence as the numbers in the text. •Names of journals should be abbreviated according to Index Medicus ( http://www.nlm.nih.gov/tsd/serials/lji.html)
Examples:
1. Books: [1]Zucherman AJ, Smith O, Clark J et al. Infectious mononucleosis. In Top FH and Wehrle PF (eds) Communicable and Infectious Diseases. 2nd edn, St Louis: CV Mosby, 1990, pp 558-9. 2. Journals: [1]Greenland KJ, Zajac JD. Kennedy's disease: pathogenesis and clinical approaches. Intern Med J 2004;34:279-86.
Papers that have been accepted but not yet published should be included in the reference list followed by "(in press)". Those in preparation including those already submitted for ublication, personal communications and unpublished observations should be referred to in the text only.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as 'graphics' or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Submission checklist
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded, and contain:
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black-and-white versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site at http://support.elsevier.com.
Editorial Board
Editor-in-Chief:
Prof. A. Nehra
Mayo Clinic, Department of Urology, Rochester, MN, USA, Email: nehra.ajay@hotmail.com
Immediate Past Editor
Prof. S. Meryn
ISMH, Vienna, Austria
Associate Editors
Dr. M. Blute
University of Massachusetts Medical Center, Worcester, MA, USA
Dr. C. Carson
University of North Carolina, Chapel Hill, NC, USA
Dr. M. Miner
Miriam Hospital, Providence, RI, USA
Dr. H.M. Tan
University of Malaysia Medical Centre, Kuala Lumpur, Malaysia
Prof. M. Zitzmann
Institute of Reproductive Medicine, Münster, Germany
Section Editors
A. Araujo
Epidemiology, New England Research Institute, Watertown, MA, USA
C. Burkle
Anesthesia, Legal, Mayo Clinic, Rochester, MN, USA
R. Carrion
Urology, University of South Florida, Tampa, FL, USA
D. Crawford
Uro-Oncology, University of Colorado, Denver, CO, USA
A. Ghosh
Primary Care, Mayo Clinic, Rochester, MN, USA
J. Heidelberg
Academic Men's Health, University of Michigan, Ann Arbor, MI, USA
S. Horie
Aging Male and Sexual Health, Teikyo University, Tokyo, Japan
H. Jones
Endocrinology, Centre for Diabetes and Endocrinology, Barnsley, UK
J. Karnes
Oncology, Mayo Clinic, Rochester, MS, USA
S. Kopecky
Cardiology, Mayo Clinic, Rochester, MN, USA
D. Ohl
Urology, Infertility, University of Michigan, Ann Arbor, MI, USA
J. St. Sauver
Epidemiology, May Clinic, Rochester, MN, USA
H.M. Treadwell
Social Determinants, National Center for Primary Care, Atlanta, GA, USA
G. Williams
Primary Medicine, National Hormone and Menopause Research Centre, Queensland, Australia
A. Young
Public Health, Collins Center for Public Health, Miami, FL, USA
Regional Editors
M. Al Suwaidi
QATAR, Hamad Medical Corporation, Doha, Qatar
S. Horie
JAPAN, Teikyo University, Tokyo, Japan
R. Khauli
LEBANON, American Univiersity of Beirut, Beirut, Lebanon
R. Kumar
INDIA, All India Institute of Medical Sciences, New Delhi, India
I. Moncada Iribarren
EUROPE, Ruber International Hospital, Madrid, Spain
R. Sadovsky
USA, SUNY Medical Center, New York, NY, USA
A. White
EUROPE, Leeds University, UK
G. Williams
AUSTRALIA, National Hormone and Menopause Research Centre, Queensland, Australia
Advisory/Editorial Board
A. Araujo
New England Research Institute, Watertown, MA, USA
S. Arver
Karolinska Institute, Stockholm, Sweden
N. Bar Chama
Reproductive Medicine Associates of New York, New York, USA
C. Betocchi
University of Bari, Italy
J. Bonhomme
Emory University, Atlanta, GA, USA
V. Christov
Medical University, Sofia, Bulgaria
D. Crawford
University of Colorado, Denver, CO, USA
J. Dean
International Society of Sexual Medicine, Plymouth, UK
L. Doyal
University of Bristol, UK
W.A. Fisher
University of Western Ontario, London, ON, Canada
L. Hakim
Cleveland Clinic, Weston, FL, USA
A.A. Kamalov
Moscow State University, Russia
I. Khalaf
Al Azhara University, Cairo, Egypt
R.B. Khauhli
American University of Beirut, Lebanon
M. Khera
Baylor College of Medicine, Houston, TX, USA
A. Kiss
University Clinics, Basel, Switzerland
P. Maguire
European Institute for Women's Health, Dublin, Ireland
M. Marberger
University of Vienna, Austria
E. Meuleman
University of Amsterdam, The Netherlands
I. Moncada Iribarren
Ruber International Hospital, Madrid, Spain
P. Montorsi
University of Milan, Italy
F. Montorsi
San Raffaele University, Milan, Italy
J.E. Morley
St. Louis University, MO, USA
J.S. Palmer
Cleveland Clinics, Cleveland, OH, USA
A. Rieder
Medical University of Vienna, Austria
A. Robbins
University of Cambridge, MA, USA
R. Tan
University of Texas, Houston, TX, USA
M.D. Waldinger
Haga Hospital, Utrecht, The Netherlands
A.A. Yassin
Segeburger Clinics, Hamburg, Germany
A. Young
Collins Center for Public Health, Miami, FL, USA
|
